Navigation Links
Research Sheds Light on Cause of Brain Deficits in HIV Patients
Date:6/28/2011

TUESDAY, June 28 (HealthDay News) -- Some HIV patients experience memory loss and other neurological deficits, despite treatment, and new research suggests that the reason why is because the virus weakens the blood-brain barrier by infecting a small group of supporting brain cells called astrocytes.

The blood-brain barrier is a network of blood vessels that protects the brain from harmful chemicals and toxins. In healthy people, astrocytes help bolster the blood vessels that comprise the blood-brain barrier.

The finding, published in the June 29 issue of the Journal of Neuroscience, may help explain why 40 percent to 60 percent of HIV patients on antiretroviral therapy experience mild to moderate neurological problems such as learning difficulties.

For this study, the researchers built a model of the blood-brain barrier using human cells in the laboratory. The research was supported by the U.S. National Institute of Mental Health.

"Our results suggest HIV infection of astrocytes may be important in the onset of cognitive impairment in people living with the disease," study author Eliseo Eugenin, of Albert Einstein College of Medicine, said in a news release from the Society for Neuroscience.

"New therapies are needed that not only target the virus, but also to stop the virus from spreading damage to other uninfected brain cells," Eugenin added.

"Researchers have been stymied to explain why HIV-associated neurological complications persist, despite potent combination antiviral therapies that have dramatically improved health and survival," Igor Grant, an expert in HIV-associated neurocognitive impairment at the University of California, San Diego, said in the news release.

"This study provides a possible explanation indicating that minute numbers of infected astrocytes can trigger a cascade of signals that could open the brain to various toxic influences," explained Grant, who was not involved with the study.

More information

The American Psychiatric Association has more about mental health and HIV/AIDS.

-- Robert Preidt

SOURCE: Society for Neuroscience, news release, June 28, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Researchers at Oregon Health & Science University discover MS-like disease in monkeys
2. Van Andel Research Institute finding could lead to reduced side effects in anti-cancer antibiotics
3. Religion benefits traumatic brain injury victims, Wayne State University research finds
4. Leading research organizations announce top-tier journal for biomedical and life sciences
5. New Crops for the Future Research Centre -- for food and non-food uses
6. Drug shows improved kidney function for type 2 diabetics, UT Southwestern researchers report
7. UH Cancer Center receives $3.58 million gift for mesothelioma research
8. New application for iPhone may support monitoring and research on Parkinsons disease
9. TGen, Tecan and ASU Biodesign Institute develop sample preparation solution for proteomic research
10. Researchers identify components of speech recognition pathway in humans
11. Slowing the spread of drug-resistant diseases is goal of new research area
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Research Sheds Light on Cause of Brain Deficits in HIV Patients
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class ... support to bring their novel lifesaving device for the everyday use of parents ... sensors, specially designed to read a child’s vital signs, and detect unusual symptoms ...
(Date:4/24/2017)... Ill., and Waycross, Ga. (PRWEB) , ... April ... ... market leader and trusted advisor within the telehealth industry, announces the company’s VideoMedicine ... U.S. board-certified primary care providers. Available 24 hours a day, Quick Care provides ...
(Date:4/24/2017)... ... April 24, 2017 , ... According ... overdose deaths now claim the lives of 62 Americans each day.(1) Yet since ... drug manufacturers, distributors, pharmacies and prescribers by more than half.(2) Novus Medical ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... recognize elevated anxiety levels in people with addiction who are served by MAP’s ... a biosensing wearable device that monitors heart and breath rates to identify anxiety ...
(Date:4/24/2017)... ... 2017 , ... Pitavastatin, a relatively new statin, has relevance ... to have significant interactions with antiretroviral therapy (ART). Among people living with ... inflammation in the bloodstream. , While lowering cholesterol and dampening inflammation are beneficial ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)...  IRIDEX Corporation (Nasdaq: IRIX ) today ... first quarter 2017 after the close of trading on ... host a corresponding conference call beginning at 2:30 p.m. ... in listening to the conference call may do so ... 326-3030 for international callers, using conference ID: 92158987.  A ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
Breaking Medicine Technology: